Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Projected CAGR for the Candesartan Cilexetil Drug Market Size from 2025 to 2034?
In the past few years, the market size of the candesartan cilexetil drug has experienced consistent growth. It is projected to escalate from $1.57 billion in 2024 to $1.65 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.0%. Factors such as the growing number of hypertension cases, the increase in the elderly population, the rising occurrence of chronic diseases, the amplified focus on preventive care, and the expansion of healthcare spending have all contributed to the growth during the historic period.
The market for the drug, candesartan cilexetil, is set to witness a significant increase in the coming years. Projected to surge to a value of $2.04 billion by 2029, it will experience a compound annual growth rate (CAGR) of 5.5%. The upcoming growth can be traced back to a rise in generic drug production, an amplified number of lifestyle-related diseases, government-led moves towards affordable care for hypertension, a higher occurrence rate of cardiovascular diseases, and the widespread adoption of combination therapies. Looking ahead, the market is poised for changes such as a swing towards generic candesartan formulations, creation of fixed-dose combination drugs, integration of digital health in hypertension monitoring, increased attention to patient adherence, and further research into new delivery methods.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24183&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Candesartan Cilexetil Drug Market?
The escalating occurrence of hypertension is poised to drive the growth of the candesartan cilexetil drug market. Hypertension, alternatively known as high blood pressure, is a health condition characterized by the force of blood on the walls of arteries being persistently too significant, generally identified as a reading of 130/80 mmHg or more. The pervasiveness of hypertension is primarily attributable to an elevated prevalence of unhealthy lifestyle habits including poor nutrition, inadequate physical exercise, and excessive stress levels. The drug candesartan cilexetil aids in hypertension management by preventing the activity of angiotensin II, a hormone causing blood vessel contraction, thus relaxing the blood vessels and subsequently lowering blood pressure. For example, data from the Centers for Disease Control and Prevention, a US government agency, in October 2024 revealed that between August 2021 and August 2023, there was a substantial rise in hypertension prevalence by 124.48% among the 18-39 age group transitioning to the 40-59 age group, and an increase of 36.38% among the 40-59 age group transitioning to those aged 60 and above. Consequently, the growing incidence of hypertension is triggering a rise in demand within the candesartan cilexetil drug market.
Which Key Market Segments Comprise the Candesartan Cilexetil Drug Market and Drive Its Revenue Growth?
The candesartan cilexetil drug market covered in this report is segmented –
1) By Product Type: Tablets, Capsules, Other Product Types
2) By Indication: Hypertension, Heart Failure, Diabetic Nephropathy, Left Ventricular Hypertrophy
3) By Dosage Strength: 4 MG, 8 MG, 16 MG, 32 MG
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Healthcare Facilities
5) By Application: Adult, Children And Adolescent
Subsegments:
1) By Tablets: Immediate-Release Tablets, Extended-Release Tablets, Dispersible Tablets, Chewable Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gelatin Capsules, Modified-Release Capsules
3) By Other Product Types: Oral Suspensions, Injectable Formulations, Combination Drug Formulations
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24183&type=smp
Which Areas Are Leading Regions in the Candesartan Cilexetil Drug Market Expansion Across the Globe?
North America was the largest region in the candesartan cilexetil drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candesartan cilexetil drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theCandesartan Cilexetil Drug Market Over the Coming Years?
Leading businesses in the candesartan cilexetil drug market are concentrating their efforts on developing novel formulations. These new developments include hypertension remedies, combination therapies with various antihypertensive medicines, and time-release versions designed to enhance patient compliance and improve therapeutic results. Hypertension management involves strategies such as medicinal interventions, lifestyle modifications, and other measures aimed at reducing and controlling high blood pressure, thereby mitigating associated health risks including heart disease, stroke, and kidney damage. In March 2025, for example, Scienture Inc., an American pharmaceutical firm, secured US Food & Drug Administration (USFDA) approval for its New Drug Application (NDA) for SCN-102, marketed as Arbli. This oral suspension of losartan potassium (10 mg/mL) acts as an angiotensin II receptor blocker (ARB) and provides a substitute for those who struggle swallowing pills, particularly among children and elders. The introduction of this medication highlights the increasing demand for alternative dosage formats in the antihypertensive market and underscores the transition towards patient-centric, user-friendly drug delivery mechanisms.
View the full report here:
https://www.thebusinessresearchcompany.com/report/candesartan-cilexetil-drug-global-market-report
How Is the Candesartan Cilexetil Drug Market Conceptually Defined?
Candesartan cilexetil drug refers to an angiotensin II receptor antagonist used primarily to treat high blood pressure and heart failure. It works by blocking the effects of angiotensin II, helping to relax blood vessels and reduce blood pressure.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24183
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model